UBX

Unity Biotechnology, Inc.

1 day chart

About UBX

Unity Biotechnology, Inc. is engaged in developing therapeutics to slow, halt, or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells. The Company is also focused on advancing senolytic programs primarily in ophthalmologic disorders. It is also focused on advancing other programs based on other biologies of aging to include an agonistic antibody to the Tie2 receptor and a Tie2/vascular endothelial growth factor (VEGF) bispecific to treat vascular eye disease. The Company's UBX1325 and UBX1967 are designed to inhibit the function of proteins that senescent cells rely on for survival. UBX1325 is an advanced drug candidate for age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration, (AMD), and diabetic retinopathy (DR). Its UBX2050 is an investigational, fully human anti-Tie2 agonist monoclonal antibody.

Market Capitalisation

$35.04M

Price-earnings ratio

Dividend yield

0.00%

Volume

38.72K

High today

$2.45

Low today

$2.35

Open price

$2.43

52-week high

$5.72

52-week low

$1.46

UBX FAQs

Can I buy UBX shares through Stake, an investing platform like Freetrade, eToro or IG Markets?

Yes, the Stake platform allows you to buy UBX shares and over 6,000 stocks and ETFs on Wall St.

How much is one share of Unity Biotechnology, Inc.?

One share of Unity Biotechnology, Inc. is valued at 2,57 $.

What is the ticker symbol for Unity Biotechnology, Inc.?

The ticker symbol for Unity Biotechnology, Inc. is UBX.

How do I buy UBX shares in Australia?

To buy UBX stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in UBX

What is the 52-week high for Unity Biotechnology, Inc. stock?

The Unity Biotechnology, Inc. 52-week high stock price is 5,72 $.

What is the 52-week low for Unity Biotechnology, Inc. stock?

The Unity Biotechnology, Inc. 52-week low stock price is 1,46 $.

What is the market capitalisation of Unity Biotechnology, Inc. UBX?

As of 29/09/2023 Unity Biotechnology, Inc. has a market cap of $35 млн.

Related Stocks

When you invest, your capital is at risk. The value of investments can go up as well as down and you may receive back less than your original investment. Any advice is of a general nature only. As all investments carry risk, before making any investment decision, consider if it's right for you and seek appropriate advice from a licensed tax or financial advisor. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.